Skye Bioscience, Inc. (SKYE)
1.055
-0.14
(-11.34%)
USD |
NASDAQ |
Dec 17, 16:00
1.055
0.00 (0.00%)
After-Hours: 18:37
Skye Bioscience Accounts Payable (Quarterly): 2.825M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 14.66M |
| Harrow, Inc. | 18.99M |
| Theravance Biopharma, Inc. | 2.213M |
| Viking Therapeutics, Inc. | 4.413M |
| FibroGen, Inc. | 5.093M |